408 evidence-linked molecules — 5 currently mapped to an Abiozen canonical molecule, 403 not yet mapped. Ordering is alphabetical and neutral; this is an evidence view, not a ranking.
Prioritize — inhibition potency (IC50) →| Molecule | Representative activity | Evidence | Abiozen identity | Commercial |
|---|---|---|---|---|
|
CHEMBL65406
CHEMBL65406
|
IC50 4000 nM | 1 | Not yet mapped | — |
|
CHEMBL66032
CHEMBL66032
|
IC50 11 nM | 1 | Not yet mapped | — |
|
CHEMBL66189
CHEMBL66189
|
IC50 30000 nM | 1 | Not yet mapped | — |
|
CHEMBL67089
CHEMBL67089
|
IC50 16000 nM | 1 | Not yet mapped | — |
|
CHEMBL67679
CHEMBL67679
|
IC50 20 nM | 2 | Not yet mapped | — |
|
CHEMBL67680
CHEMBL67680
|
IC50 30 nM | 2 | Not yet mapped | — |
|
CHEMBL77539
CHEMBL77539
|
IC50 8 nM | 4 | Not yet mapped | — |
|
CHEMBL88474
CHEMBL88474
|
IC50 14.1 ug.mL-1 | 2 | Not yet mapped | — |
|
CHEMBL88953
CHEMBL88953
|
IC50 12.8 ug.mL-1 | 2 | Not yet mapped | — |
|
CHEMBL89081
CHEMBL89081
|
IC50 100 ug.mL-1 | 2 | Not yet mapped | — |
|
CHEMBL8916
CHEMBL8916
|
IC50 100 ug.mL-1 | 2 | Not yet mapped | — |
|
CHEMBL90616
CHEMBL90616
|
IC50 100 ug.mL-1 | 2 | Not yet mapped | — |
|
CHEMBL91130
CHEMBL91130
|
IC50 100 ug.mL-1 | 2 | Not yet mapped | — |
|
CHEMBL92028
CHEMBL92028
|
IC50 104 nM | 1 | Not yet mapped | — |
|
CHEMBL92175
CHEMBL92175
|
Ki 5 nM | 1 | Not yet mapped | — |
|
CHEMBL9237
CHEMBL9237
|
IC50 47000 nM | 1 | Not yet mapped | — |
|
CHEMBL9238
CHEMBL9238
|
IC50 36 nM | 1 | Not yet mapped | — |
|
CHEMBL9263
CHEMBL9263
|
IC50 800 nM | 1 | Not yet mapped | — |
|
CHEMBL92706
CHEMBL92706
|
Ki 4200 nM | 1 | Not yet mapped | — |
|
CHEMBL92710
CHEMBL92710
|
IC50 256 nM | 1 | Not yet mapped | — |
|
CHEMBL92711
CHEMBL92711
|
IC50 33 nM | 1 | Not yet mapped | — |
|
CHEMBL92760
CHEMBL92760
|
Ki 21 nM | 1 | Not yet mapped | — |
|
CHEMBL9295
CHEMBL9295
|
IC50 30 nM | 1 | Not yet mapped | — |
|
CHEMBL93034
CHEMBL93034
|
IC50 7000 nM | 1 | Not yet mapped | — |
|
CHEMBL93060
CHEMBL93060
|
Ki 0.5 nM | 1 | Not yet mapped | — |